UNPACKED

← Frontpage

GLP-1 Won’t Kill Cake. It Will Resize It.

1h ago · 6 sources · trend

The GLP-1 panic cycle is in full swing. Headlines scream that people will eat less and entire categories will collapse. The data says something more nuanced.

Around 13.3% of US consumers are now using GLP-1 medications, and adoption could reach 21% by 2030. That is big. Roughly 40 million Americans are already on them. But the American Bakers Association is clear. This is not a demand cliff. It is a behavior shift.

People are not walking away from bakery and confectionery. They are eating differently. Smaller portions. More frequent occasions. Less mindless grazing. Appetite drops, but routine, comfort and celebration do not.

Confectionery data backs it up. Consumers are leaning into selective indulgence, not reduced indulgence. They still want the real thing. They just want it to feel worth it.

For bakery, that likely means fewer five-for-a-pound bags and more single, premium moments. Smaller packs. More premium SKUs. Stronger flavors. Higher protein and fiber where it makes sense. If a consumer is only eating one brownie instead of two, that brownie better earn its place.

The industry question is not "How do we survive less eating?" It is "How do we win when every bite counts more?"

Key facts

  • Around 13.3% of US consumers are using GLP-1 medications, according to the ABA’s 2026 Bakery Playbook.
  • Adoption of GLP-1 medications could reach around 21% by 2030, as awareness grows, access improves and use becomes more socially accepted.
  • Economic futurist Andy Busch told attendees that around 40 million Americans are already using GLP-1 medications.
  • GLP-1s are not driving a mass exit from food categories, but reshaping how, when and how much people eat.
  • Smaller portions and more frequent eating occasions are changing consumption patterns, not eliminating them.
  • Consumers are turning to selective indulgence not reduced indulgence, meaning they still want real treats but may indulge less often.
  • The rise of GLP-1 points towards smaller packs, more premium SKUs and products that deliver a proper moment of indulgence.
  • 13.3%
  • 21%
  • 40 million

Coverage